Opendata, web and dolomites

GlucoTab

A Novel ICT Assistant Solution for de-Risked Management of Insulin Dosing and Blood Glucose Levels in Hospitalized Patients with Type 2 Diabetes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GlucoTab project word cloud

Explore the words cloud of the GlucoTab project. It provides you a very rough idea of what is the project "GlucoTab" about.

extremely    paper    patient    day    cumulative    rely    easing    solution    wrong    regimen    glucotab    adaptable    50    glucose    care    physiological    daily    13    multiple    risk    42    standardize    recommend       adjustments    precise    full    ict    medication    centric    suffer    risks    admissions    assist    flow    follow    incurred    diabetic    created    dosing    therapy    lack    hospital    calculations    flexible    becomes    rising    stay    inefficient    beds    error    automate    combining    conceived    least    integration    revenues    days    hospitals    decisions    suitable    bolus    efficient    errors    market    reducing    encloses    judgment    responsible    workload    guidelines    alarming    charts    bedside    diabetes    arduous    disease    software    ups    despite    turn    clinical    decision    impacted    basal    complicated    enrolling    guidance    incorrect    patients    incidence    wards    blood    device    persistent    medical    mimic    treatment    believe    hypoglycemia    hyperglycemia    600    launch    overwhelming    healthcare    insulin    hazardous    saturated    prescription    secretion   

Project "GlucoTab" data sheet

The following table provides information about the project.

Coordinator
DECIDE CLINICAL SOFTWARE GMBH 

Organization address
address: NEUE STIFTINGTALSTRASSE 2
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website http://www.glucotab.at
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECIDE CLINICAL SOFTWARE GMBH AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

'Despite being responsible for up to 1/3 of admissions, the management of type 2 diabetes in hospital wards is still extremely challenging. European clinical guidelines recommend prescription of 'basal-bolus insulin therapy' as it is the most flexible, adaptable and precise regimen available to mimic the physiological secretion of insulin. However, it requires a patient-centric approach with multiple daily follow-ups. Since both persistent hypoglycemia (due to incorrect medication) and hyperglycemia (due to disease) are hazardous, diabetic care requires day-to-day decisions combining medical judgment and clinical findings. This overwhelming task is even more complicated due to the current inefficient methods that rely on by-hand calculations and paper-based charts. Thus, management becomes a complex task, increasing the workload for the already saturated personnel. Most importantly, it increases the overall risk of medical errors. Indeed, 42% in-hospital days are impacted by treatment errors, wrong blood glucose measurements or lack of adjustments on insulin dosing. Thus, 50% of patients suffer at least one medication error during their stay. In response, we have created GlucoTab, an ICT-based software able to assist on the arduous decision-making process daily incurred in the management of type 2 diabetes. GlucoTab will automate and standardize task management, reducing risks, costs and easing the personnel's work-flow. Conceived as a medical device, our product is able to offer guidance on the most suitable insulin dosing regimen for a patient. By enabling the full integration of the patient's bedside management with the general hospital information system, we believe that GlucoTab encloses a cost-efficient solution that will allow hospitals and healthcare systems to face the alarming rising incidence of diabetes. In turn, GlucoTab will provide us estimated cumulative revenues of €7.7 M after enrolling 13,600 beds within five years from market launch.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLUCOTAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLUCOTAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

WIMUACT (2017)

TECHNOLOGY FOR THE IMPROVEMENT OF SPORTS PERFORMANCE IN NON-PROFESSIONAL CONTEXTS

Read More  

Enterprise BIM (2017)

Enterprise BIM digitization platform feasibility verification

Read More  

Revault (2015)

Revault - world´s first wearable private cloud. Securely sync and access your files from anywhere without an internet connection.

Read More